For years, cardiovascular disease, chronic kidney disease, type 2 diabetes, obesity, and hypertension have often been managed as separate conditions. The newly released 2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome challenges that approach by recognizing these conditions as interconnected and calling for earlier, more coordinated care importantly, this is the first-ever clinical practice guideline dedicated specifically to CKM syndrome. Developed collaboratively by the American Heart Association (AHA), American College of Cardiology (ACC), American Diabetes Association (ADA), and American Society of Nephrology (ASN), the guideline replaces the previous 2013 obesity guideline with a broader framework that reflects today’s understanding of how cardiovascular, kidney, and metabolic diseases influence one another. Rather than focusing on a single disease state, it emphasizes identifying risk earlier, treating patients more comprehensively, and preventing progression before complications develop. zrób z tego slajdy po polsku, białe tło, granotowe literki aktrakcyje wizuolanie z obrazkami szkocowanymi